WFDC2 and cancer: We used the Olink Target 96 Oncology II panel and assessed the discriminative capacity of a total of 92 cancer‐related proteins, including HE4 and CA125, for the prospective detection of EC through measurements in plasma and serum samples that had been collected up to 2 years prior to diagnosis.